Capricor Therapeutics, Inc. CAPR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

64/100

2/6 Pass

SharesGrow Intrinsic Value

Capricor Therapeutics, Inc. (CAPR) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Nippon Shinyaku Co Ltd 7,090,351 주 보유. 기타 주요 보유자에는 FOUNTAINHEAD CAPITAL PARTNERS LTD 및 CEDARS SINAI MEDICAL CENTER.

지난 12개월간 내부자는 17 건의 거래를 수행 CAPR 주식 — 10 건 매수 (평가액 $3.76M) 및 3 건 매도 (평가액 $2.84M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

CAPR 내부자 보유 현황

최대 보유자

Nippon Shinyaku Co Ltd

7,090,351 주

매수 (12개월)

$3.76M 평가액

매도 (12개월)

$2.84M 평가액

12개월 거래 활동

매수 59%

매도 18%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Nippon Shinyaku Co Ltd	10 Percent Owner	7,090,351	2024-09-24	100%
2	Fountainhead Capital Partners Ltd	10 Percent Owner	5,551,000	2006-08-21	78%
3	Cedars Sinai Medical Center	10 Percent Owner	4,049,959	2017-05-11	57%
4	Wexford Capital Llc	10 Percent Owner	696,675	2007-09-19	10%
5	St. John Edward A.	10 Percent Owner	208,333	2016-03-18	3%
6	Marban Eduardo	10 Percent Owner	199,509	2017-02-06	3%
7	Kazam Joshoa A	Director	165,530	2007-09-19	2%
8	Strumph Peter M	Chief Executive Officer	149,148	2009-01-20	2%
9	Granadillo Pedro P	Director	100,000	2011-05-12	1%
10	Brewer Richard B	Executive Chairman	93,750	2012-04-02	1%
11	Belldegrun Arie	Director	80,000	2011-05-12	1%
12	Mieyal Paul A	Director	80,000	2011-05-12	1%
13	Tanen David M	Director	65,000	2009-07-23	1%
14	Smith Rachel	Vice President of R&d	50,000	2018-01-04	1%
15	Litvack Frank	Director	50,000	2026-01-07	1%
16	Ascheim Deborah	Chief Medical Officer	50,000	2018-07-25	1%
17	Hamer Andrew Warwick	VP of Medical Affairs	25,000	2015-03-05	0%
18	Kash Peter M	Director	19,500	2011-07-19	0%
19	Schafer Gregory W	Director	17,500	2015-03-05	0%
20	Gotwals Philip J	Director	15,500	2026-01-07	0%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-04-02	Sabar Karimah Es	Director	정보 매도	7,529	$32.00	$240.93K
2026-04-01	Sabar Karimah Es	Director	옵션 행사 (매도)	53,735	$4.86	$261.15K
2026-03-31	Sabar Karimah Es	Director	정보 매도	61,265	$30.17	$1.85M
2026-03-31	Bergmann Anthony	Chief Financial Officer	정보 매도	25,000	$30.13	$753.15K
2026-03-31	Krasney Karen	EVP, General Counsel	옵션 행사 (매도)	693	$1.39	$963.27
2025-12-30	Krasney Karen	EVP, General Counsel	옵션 행사 (매도)	2,500	$1.39	$3.48K
2026-01-05	Kelliher Mike	Director	RSU 부여	15,500	$24.81	$384.56K
2026-01-05	Auwaerter Paul Gisbert	Director	RSU 부여	1,360	$24.81	$33.74K
2026-01-05	Gotwals Philip J	Director	RSU 부여	15,500	$24.81	$384.56K
2026-01-05	Sabar Karimah Es	Director	RSU 부여	15,500	$24.81	$384.56K
2026-01-05	Bergmann Anthony	Chief Financial Officer	RSU 부여	2,500	-	-
2026-01-05	Krasney Karen	EVP, General Counsel	RSU 부여	22,500	$24.81	$558.23K
2026-01-05	Marban Linda	Chief Executive Officer	RSU 부여	7,500	-	-
2026-01-05	Litvack Frank	Director	RSU 부여	50,000	$24.81	$1.24M
2026-01-05	Musket David B	Director	RSU 부여	15,500	$24.81	$384.56K
2026-01-05	Dunbar George W Jr	Director	RSU 부여	15,500	$24.81	$384.56K
2025-12-19	Dunbar George W Jr	Director	옵션 행사 (매도)	3,000	$1.39	$4.17K